With new technologies that allow drugs to be tested directly in human biological systems, researchers are beginning to ...
Discover why Recursion Pharmaceuticals, Inc. stands out in AI drug discovery, but faces valuation risks. Click for my look at ...
20h
New Book Shows How The Right Culture And Strategy Drive Breakthroughs In Drug And Device Development
How People, Process, and Systems Transform the Business of Life Sciences” by Gary K. Zammit, PhD, is released with Forbes ...
Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced the completion ...
Lonza helps biotech firms accelerate from DNA to IND with tailored strategies that reduce risk and speed complex biologics to ...
China will require licenses for the exportation of the precursor chemicals that can be turned into fentanyl for shipment to North America.
An international team involving the Institute of Chemical Research, a joint center of the University of Seville and the ...
Earlier this year, researchers at Children's Hospital of Philadelphia and Penn created a first-of-its-kind drug customized to ...
An international team involving the Institute of Chemical Research, a joint centre of the University of Seville and the ...
The “plausible mechanism” pathway, outlined by Martin Makary and Vinay Prasad, is designed to help accelerate treatments ...
Innovation in drug development has never moved faster! New modalities, real-world evidence, complex patient stratification, and AI are reshaping what’s possible. Yet one of the biggest bottlenecks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback